Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS)

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Child Neurology

• Publication date

  2015-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/0883073814549581PMID 25342308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bayley Scales of Infant and Toddler Development

  2017cited by this paper
• Adaptive Behavior Assessment System—Second Edition

  2014cited by this paper
• BAYLEY SCALES OF INFANT AND TODDLER DEVELOPMENT, THIRD EDITION (BAYLEY-III)

  2014cited by this paper
• Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome

  2012cited by this paper
• Wechsler Preschool and Primary Scale of Intelligence—Fourth Edition

  2012cited by this paper
• Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome

  2011cited by this paper
• Long-Term Follow-Up of Neuroblastoma-Associated Opsoclonus-Myoclonus-Ataxia Syndrome

  2009cited by this paper
• Insights on Chronic-Relapsing Opsoclonus-Myoclonus From a Pilot Study of Mycophenolate Mofetil

  2009cited by this paper
• Long-term outcome of ten children with opsoclonus-myoclonus syndrome

  2007cited by this paper
• High Dose Pulsatile Dexamethasone Therapy in Children with Opsoclonus-Myoclonus Syndrome

  2006cited by this paper
• Rituximab (anti-CD20) Adjunctive Therapy for Opsoclonus-Myoclonus Syndrome

  2006cited by this paper
• Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia.

  2006cited by this paper
• Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.

  2005cited by this paper
• Longitudinal Neurodevelopmental Evaluation of Children With Opsoclonus-Ataxia

  2005cited by this paper
• B- and T-cell markers in opsoclonus–myoclonus syndrome

  2004cited by this paper
• B- and T-cell markers in opsoclonus–myoclonus syndrome: Immunophenotyping of CSF lymphocytes

  2004cited by this paper
• CSF B‐cell expansion in opsoclonus‐myoclonus syndrome: A biomarker of disease activity

  2004cited by this paper
• Immunologic and Clinical Responses to Rituximab in a Child With Opsoclonus-Myoclonus Syndrome

  2004cited by this paper
• Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.

  2002cited by this paper
• Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and visceral adiposity, and effects of physical training.

  2002cited by this paper
• Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

  2001cited by this paper
• Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma.

  1998cited by this paper
• Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.

  1997cited by this paper
• Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus.

  1996cited by this paper
• Treatment of opsoclonus-myoclonus with highdose intravenous immunoglobulin

  1996cited by this paper
• Neurological sequelae of the dancing eye syndrome

  1996cited by this paper
• NEUROBEHAVIORAL AND PSYCHOSOCIAL FUNCTIONING OF CHILDREN WITH OPSOCLONUS‐MYOCLONUS SYNDROME

  1995cited by this paper
• High‐dose iv human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome

  1992cited by this paper
• [Myoclonic encephalopathy (Kinsbourne syndrome)].

  1984cited by this paper
• Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma

  1976cited by this paper
• Favorable prognosis for survival in children with coincident opso‐myoclonus and neuroblastoma

  1976cited by this paper
• Myoclonic encephalopathy of infants

  1962cited by this paper

• Neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: an important yet overlooked diagnosis in pediatric ataxia

  2026cites this paper
• Diagnostic Detour: A Case of Opsoclonus-Myoclonus-Ataxia Syndrome Initially Misdiagnosed As Tricyclic Antidepressant Toxicity in a Child

  2026cites this paper
• HLA and T-Cell Receptor Investigations in Idiopathic and Paraneoplastic Opsoclonus-Myoclonus in Children

  2026cites this paper
• The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae

  2025influential citation
• Motor, cognitive, affective, and communication outcomes in patients with sustained remission of opsoclonus-myoclonus-ataxia syndrome.

  2025cites this paper
• Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome can Lead to Long-Term Neurological, Neuropsychological, and Cognitive Sequelae Associated with Cerebellar Atrophy

  2025cites this paper
• Paraneoplastic cerebellar and brainstem disorders.

  2024cites this paper
• Pediatric Opsoclonus myoclonus syndrome with improvement of symptoms and decrease in cerebrospinal fluid B cell percentage after Rituxmab administration: Case report

  2024cites this paper
• Inaugural Patient-Reported Registry of Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome: Presentation, Diagnosis, and Treatment of 194 Patients.

  2024influential citation
• Late cognitive and adaptive outcomes of patients with neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia‐syndrome: A report from the Children's Oncology Group

  2024influential citation
• Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood

  2024cites this paper
• Characteristics of Opsoclonus-Myoclonus Syndrome in Patients of the Largest Pediatric Hospital in Latin America.

  2024cites this paper
• Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): a collaborative review of the current understanding

  2023cites this paper
• An International Pediatric-Onset Opsoclonus-Myoclonus Ataxia Syndrome Registry and Clinical Research Network: Development, Progress, and Vision.

  2023cites this paper
• Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.

  2023cites this paper
• Five Years Follow-up of Opsoclonus–Myoclonus–Ataxia Syndrome-Associated Neurogenic Tumors in Children

  2022cites this paper
• “Pediatrician’s Approach to Recognizing Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome”

  2022cites this paper
• Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.

  2022cites this paper
• Presence of identical B-cell clone in both cerebrospinal fluid and tumor tissue in a patient with opsoclonus–myoclonus syndrome associated with neuroblastoma

  2022cites this paper
• Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature.

  2022cites this paper
• Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children

  2022cites this paper
• Opsoclonus-myoclonus syndrome: clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort.

  2022cites this paper
• Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge

  2021cites this paper
• Clinical Analysis of Pediatric Opsoclonus-Myoclonus Syndrome in One of the National Children's Medical Center in China

  2021cites this paper
• Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes

  2021influential citation
• Long-term neurological outcomes of children with neuroblastoma with opsoclonus-myoclonus syndrome

  2021cites this paper
• Movement Disorders in the Structure of the Different Mental Processes Types in Child with Opsoclonus-Myoclonus Syndrome

  2020cites this paper
• Autoimmune and Autoantibody-Associated Encephalomyelopathies

  2020cites this paper
• [Opsoclonus-myoclonus syndrome: Experience in a tertiary hospital in the last 12 years].

  2020cites this paper
• The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

  2020influential citation
• Síndrome opsoclonus - mioclonus

  2020cites this paper
• Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience

  2020cites this paper
• IQ predictors in pediatric opsoclonus myoclonus syndrome: a large international cohort study

  2020influential citation
• The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours—Single-Centre Experience and Literature Review

  2020cites this paper
• Opsoclonus-myoclonus syndrome: clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort.

  2020cites this paper
• Neuroblastoma

  2020cites this paper
• Modern principles of diagnosis and treatment of Kinsbourne encephalopathy (a clinical case)

  2020cites this paper
• Paraneoplastic Neurologic Syndromes

  2020cites this paper
• Opsoclonus-myoclonus syndrome: Experience in a tertiary hospital in the last 12 years

  2020cites this paper
• Current therapies and therapeutic decision making for childhood‐onset movement disorders

  2019cites this paper
• An upfront immunomodulatory therapy protocol for pediatric opsoclonus‐myoclonus syndrome

  2019cites this paper
• Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.

  2018cites this paper
• Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma.

  2018cites this paper
• Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome

  2018cites this paper
• [Psychological development of children with opsoclonus myoclonus syndrome and its correlation with age and disease onset].

  2018cites this paper
• Current behavioral assessments of movement disorders in children

  2018cites this paper
• Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study.

  2018cites this paper
• Update on opsoclonus–myoclonus syndrome in adults

  2018cites this paper
• Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children

  2018cites this paper
• Neuroblastoma

  2018cites this paper
• Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study

  2017influential citation
• Rapid Resolution of Enterovirus 71-Associated Opsoclonus Myoclonus Syndrome on Intravenous Immunoglobulin

  2017cites this paper
• Rituximab, IVIg, and Tetracosactide (ACTH1–24) Combination Immunotherapy (“RITE-CI”) for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations

  2017cites this paper
• Clinical Applications of Intravenous Immunoglobulins in Child Neurology.

  2017cites this paper
• Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?

  2017cites this paper
• Autoimmune Encephalitis in Children

  2017cites this paper
• Therapie der immunvermittelten paraneoplastischen neurologischen Erkrankungen

  2017cites this paper
• Immune-Mediated CNS Diseases: a Review

  2017cites this paper
• Acute and Chronic Therapies in Pediatric Inflammatory Central Nervous System Diseases

  2017cites this paper
• Autoimmune Movement Disorders in Children.

  2017cites this paper
• Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome.

  2017cites this paper
• Principles and approaches to the treatment of immune-mediated movement disorders.

  2017cites this paper
• Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial

  2017cites this paper
• Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors.

  2017cites this paper
• Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders

  2017cites this paper
• Management of Immune-Mediated Paraneoplastic Neurological Disorders

  2017cites this paper
• Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome.

  2016influential citation
• Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.

  2016cites this paper
• Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment

  2016cites this paper
• Autoimmune neurologic disorders in children.

  2016cites this paper
• The “neuro” of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder

  2016cites this paper
• Movement Disorders Presenting in Childhood

  2016cites this paper
• Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.

  2016cites this paper
• Genetic features of neuroblastic tumors associated with opsoclonus-myoclonus syndrome opens up the possibility for detection in peripheral blood

  2016cites this paper
• Therapeutic decision making in autoimmune and inflammatory disorders of the central nervous system in children

  2016influential citation
• Opsoclonus-Myoclonus-Ataxia Syndrome in Children: Clinical Characteristics and Treatment Response

  2016cites this paper
• Review article Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome

  2016cites this paper
• Sensory Processing Difficulties in Opsoclonus-Myoclonus Syndrome

  2016cites this paper